Pfizer, Novo Nordisk escalate bidding war for obesity drug developer Metsera – Reuters

  1. Pfizer, Novo Nordisk escalate bidding war for obesity drug developer Metsera  Reuters
  2. Pfizer tops estimates, raises profit guidance even as sales fall  CNBC
  3. Pfizer’s revenue falls as COVID sales and vaccine recommendations continue to fade  MarketWatch
  4. Pfizer Boosts Profit View While Chasing Obesity Startup Metsera  Bloomberg.com
  5. Pfizer Inc. Stock (PFE) Opinions on Recent Earnings Report  Quiver Quantitative

Continue Reading